Market Tracker

11/21 6:05pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.06
Data as of Nov 21
 -0.15 / -2.88%
Today’s Change
3.20
Today|||52-Week Range
10.64
+34.22%
Year-to-Date

Today’s Trading

Previous close5.21
Today’s open5.22
Day’s range4.91 - 5.35
Volume757,578
Average volume (3 months)528,202
Market cap$314.8M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...-0.46-2.63%
AGTCApplied Genetic Tech...+0.44+2.27%
CORTCorcept Therapeutics...-0.04-1.32%
TKAITokai Pharmaceutical...-0.02-0.13%
Data as of 3:59pm ET, 11/21/2014

Financials

Next reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts